Comparing ultrasound-guided and non-guided nerve block for shoulder pain in stroke patients
Comparison of the Efficacy of Ultrasound Guided vs Non-guided Suprascapular Nerve Block Treatment in Stroke Patients With Hemiplegic Shoulder Pain.
This study is testing whether using ultrasound to guide a nerve block can help relieve shoulder pain better than doing it without guidance in stroke patients.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 25 Years to 75 Years |
| Sex | All |
| Sponsor | Abant Izzet Baysal University Academic / other |
| Locations | 1 site (Bolu) |
| Trial ID | NCT05260125 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of ultrasound-guided versus non-guided suprascapular nerve block in treating hemiplegic shoulder pain, a common complication following a stroke. Patients aged 25-75 with shoulder pain lasting over three months and a Visual Analogue Scale (VAS) score greater than 3 will be included. The study will be conducted as a prospective randomized trial, comparing the two methods of nerve block administration. The goal is to determine which technique provides better pain relief and improves rehabilitation outcomes for stroke patients.
Who should consider this trial
Good fit: Ideal candidates are hemiplegic patients aged 25-75 with shoulder pain lasting at least three months and a VAS score greater than 3.
Not a fit: Patients with cognitive impairments, uncontrolled diabetes, or recent shoulder injections may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more effective pain management strategies for stroke patients suffering from hemiplegic shoulder pain.
How similar studies have performed: While there is limited literature directly comparing these two techniques, nerve blocks have been widely used in pain management, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Having hemiplegic shoulder pain for 3 months * Visual analogue scale score \> 3 during passive shoulder joint movement on the hemiplegic side Exclusion Criteria: * Mini mental test score \<24 * Patients with uncontrolled diabetes, coagulopathy * Botulinum toxin administration in the past six months, * Any injection in the shoulder region in the last six months * Having hypersensitivity to injection agents
Where this trial is running
Bolu
- Abant Izzet Baysal University — Bolu, Turkey (Türkiye) (Recruiting)
Study contacts
- Principal investigator: Serdar kılınç — Abant Izzet Baysal University
- Study coordinator: Serdar Kılınç
- Email: drserdarkilinc@hotmail.com
- Phone: 9050559113181
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.